SILAC-Based Quantitative Proteomic Analysis of Oxaliplatin-Resistant Pancreatic Cancer Cells

SILAC-Based Quantitative Proteomic Analysis of Oxaliplatin-Resistant Pancreatic Cancer Cells

Oxaliplatin is a commonly used chemotherapeutic drug for the treatment of pancreatic cancer. Understanding the cellular mechanisms of oxaliplatin resistance is important for developing new strategies to overcome drug resistance in pancreatic cancer. In this study, we performed a stable isotope label...

Full description

Bibliographic Details
Main Authors: Young Eun Kim, Eun-Kyung Kim, Min-Jeong Song, Tae-Young Kim, Ho Hee Jang, Dukjin Kang
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
quantitative proteomics
SILAC
pancreatic cancer
drug resistance
oxaliplatin
Online Access:https://www.mdpi.com/2072-6694/13/4/724

Internet

https://www.mdpi.com/2072-6694/13/4/724

Similar Items